Pulmonary Arterial Hypertension Market To Reach USD 12.2 Billion By 2032 | DataHorizzon Research [Yahoo! Finance]
United Therapeutics Corporation (UTHR)
Last united therapeutics corporation earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.unither.com/investor-relations
Company Research
Source: Yahoo! Finance
Fort Collins, Colorado, May 10, 2024 (GLOBE NEWSWIRE) -- The use of novel therapies and treatment strategies has encouraged significant developments for PAH. The global market for pulmonary arterial hypertension (PAH) is centered on advancing, manufacturing, and disseminating therapies designed to address this chronic and progressive ailment characterized by elevated blood pressure in the lung arteries. If left unmanaged, PAH can culminate in right heart failure, underscoring the importance of effective treatment strategies involving a combination of medications and interventions. Market growth is propelled by heightened awareness of PAH, advancements in treatment modalities, and the uptick in healthcare spending. Moreover, developing targeted therapies and combination treatments has significantly bolstered market expansion. The Pulmonary Arterial Hypertension (PAH) market is experiencing substantial growth, propelled by the increasing prevalence of the disease and heightened a
Show less
Read more
Impact Snapshot
Event Time:
UTHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
UTHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
UTHR alerts
High impacting United Therapeutics Corporation news events
Weekly update
A roundup of the hottest topics
UTHR
News
- Why Is United Therapeutics (UTHR) Up 4.8% Since Last Earnings Report? [Yahoo! Finance]Yahoo! Finance
- Here's Why United Therapeutics (UTHR) is a Strong Momentum Stock [Yahoo! Finance]Yahoo! Finance
- Investing in United Therapeutics (NASDAQ:UTHR) five years ago would have delivered you a 213% gain [Yahoo! Finance]Yahoo! Finance
- United Therapeutics Co. (NASDAQ: UTHR) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Here's Why United Therapeutics (UTHR) is a Strong Value Stock [Yahoo! Finance]Yahoo! Finance
UTHR
Earnings
- 5/1/24 - Beat
UTHR
Sec Filings
- 5/31/24 - Form SD
- 5/30/24 - Form 4
- 5/28/24 - Form 4
- UTHR's page on the SEC website